Clinical and Biochemical Effects of Multipass Hemodialysis
NCT ID: NCT01267760
Last Updated: 2013-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
12 participants
INTERVENTIONAL
2011-03-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis
NCT00375635
Protein-bound Uremic Retention Solutes and Long Nocturnal Hemodialysis: a Longitudinal Analysis
NCT00417339
Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis
NCT02488200
12 Weeks of Hemodialysis With Medium Cut-Off Filter Compared to Hemodiafiltration With Standard High-flux Filter.
NCT03416192
Optimisation of Anticoagulation in Patients on Nocturnal Hemodialysis
NCT05204810
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
12 HD patients will be studied during two dialysis sessions. The first HD will be a conventional 4 hour dialysis, using single pass dialysate. The second will be an 8-hour HD using multipass (recycled) dialysate 25-30 l. Clearance of urea, creatinine, phosphate and cobalamin will be measured both in the patient and the dialysate. Patient symptoms will be recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
conventional HD
conventional 4-hour HD
Multipass hemodialysis
8-hour dialysis using a recycled dialysis bath of 25-30 l
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multipass hemodialysis
8-hour dialysis using a recycled dialysis bath of 25-30 l
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
Exclusion Criteria
* Psychiatric disease
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Flexdialysis ApS
UNKNOWN
Herlev Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James heaf
chief physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James G Heaf, MD DMSc
Role: PRINCIPAL_INVESTIGATOR
Herlev Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herlev Hospital
Herlev, Denmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Heaf JG, Axelsen M, Pedersen RS. Multipass haemodialysis: a novel dialysis modality. Nephrol Dial Transplant. 2013 May;28(5):1255-64. doi: 10.1093/ndt/gfs484. Epub 2012 Nov 7.
Eloot S, Van Biesen W, Axelsen M, Glorieux G, Pedersen RS, Heaf JG. Protein-bound solute removal during extended multipass versus standard hemodialysis. BMC Nephrol. 2015 Apr 18;16:57. doi: 10.1186/s12882-015-0056-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
mhd1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.